376
Participants
Start Date
January 28, 2025
Primary Completion Date
November 30, 2028
Study Completion Date
December 31, 2028
Azithromycin Pfizer®
Azithromycin Pfizer® powder for oral suspension will be used in the active comparator arm: 1 daily dose for 5 days, 10mg/kg/day on day 1 and 5mg/kg/day on days 2-5
Placebo
Control comparator arm: 5 days of placebo
NOT_YET_RECRUITING
Department of Pediatrics, Department Mother-Woman-Child, Lausanne University Hospital, Switzerland, Lausanne
NOT_YET_RECRUITING
Children's Hospital of Geneva, University Hospitals of Geneva, Switzerland, Geneva
NOT_YET_RECRUITING
Department of Pediatrics, Fribourg Hospital, Switzerland, Fribourg
RECRUITING
University Children's Hospital Bern, Switzerland, Bern
RECRUITING
University of Basel Children's Hospital, Switzerland, Basel
ACTIVE_NOT_RECRUITING
Children's Hospital Aarau, Switzerland, Aarau
RECRUITING
Children's Hospital of Central Switzerland, Switzerland, Lucerne
NOT_YET_RECRUITING
Institute of Pediatrics of Southern Switzerland, EOC, Bellinzona, Switzerland, Bellinzona
RECRUITING
Department of Pediatrics, Cantonal Hospital Graubuenden, Switzerland, Chur
RECRUITING
University Children's Hospital Zurich, Switzerland, Zurich
NOT_YET_RECRUITING
Department of Pediatrics, Triemli Hospital Zurich, Switzerland, Zurich
RECRUITING
Department of Pediatrics, Cantonal Hospital Winterthur, Switzerland, Winterthur
RECRUITING
Children's Hospital of Eastern Switzerland St. Gallen, Sankt Gallen
SNF Swiss National Foundation
UNKNOWN
Swiss Clinical Trial Organisation
UNKNOWN
SwissPedNet
UNKNOWN
Christoph Berger
OTHER